Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Hodgkin Lymphoma to Oncology Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Hodgkin Lymphoma to Oncology Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Hodgkin Lymphoma Therapeutics Clinical Trials 27 Prominent Drugs 28 Latest Clinical Trials News on Hodgkin Lymphoma 29 Apr 21, 2016: Affimed Presents Data on AFM13-mediated Innate/Adaptive Immune Crosstalk at the AACR Annual Meeting 2016 29 Apr 18, 2016: Seattle Genetics Highlights Data on ADCETRIS at the American Association for Cancer Research Annual Meeting 29 Mar 17, 2016: Affimed to Present Data on AFM13 at the AACR Annual Meeting 2016 30 Clinical Trial Profile Snapshots 31 Appendix 886 Abbreviations 886 Definitions 886 Research Methodology 887 Secondary Research 887 About GlobalData 888 Contact Us 888 Disclaimer 888 Source 889

List of Tables Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region, 2016* 6 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 12 Hodgkin Lymphoma Therapeutics Clinical Trials, Central and South America, Top Countries, 2016* 13 Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 List of Figures Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Hodgkin Lymphoma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Hodgkin Lymphoma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Hodgkin Lymphoma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Hodgkin Lymphoma Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 12 Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, G7 Countries (%), 2016* 14 Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Hodgkin Lymphoma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Hodgkin Lymphoma to Oncology Clinical Trials, E7 Countries (%), 2016* 17 Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Hodgkin Lymphoma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Hodgkin Lymphoma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Hodgkin Lymphoma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Hodgkin Lymphoma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 887

Takeda Pharmaceutical Company Limited Seattle Genetics, Inc. Celgene Corporation Novartis AG Bristol-Myers Squibb Company Merck & Co., Inc. F. Hoffmann-La Roche Ltd. Sanofi Amgen Inc. AbbVie Inc.